New drug cuts hearing loss in children by 50% after cancer treatment

This article was originally published here

A clinical trial, funded by Cancer Research UK, has shown that administering sodium thiosulphate (STS) after chemotherapy ‘cisplatin’ for the treatment of childhood liver cancer hepatoblastoma reduces hearing loss in children by almost 50%.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply